Effect of sphingosine-1-phosphate on L-type calcium current and Ca(2+) transient in rat ventricular myocytes
Language English Country Netherlands Media print-electronic
Document type Journal Article
Grant support
G1002647
Medical Research Council - United Kingdom
PG/11/59/29006
British Heart Foundation - United Kingdom
PG/12/21/29473
British Heart Foundation - United Kingdom
PG/14/80/31106
British Heart Foundation - United Kingdom
PubMed
27372350
DOI
10.1007/s11010-016-2752-8
PII: 10.1007/s11010-016-2752-8
Knihovny.cz E-resources
- Keywords
- L-type calcium current, ICa,L, P21-activated kinase 1, Pak1, Sphingosine-1-phosphate, S1P,
- MeSH
- Intracellular Signaling Peptides and Proteins metabolism MeSH
- Myocytes, Cardiac metabolism MeSH
- Rats MeSH
- Lysophospholipids pharmacology MeSH
- Protein Phosphatase 2 metabolism MeSH
- Sphingosine analogs & derivatives pharmacology MeSH
- Heart Ventricles metabolism MeSH
- Calcium metabolism MeSH
- Calcium Signaling drug effects MeSH
- Calcium Channels, L-Type metabolism MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Intracellular Signaling Peptides and Proteins MeSH
- Lysophospholipids MeSH
- PAK1IP1 protein, human MeSH Browser
- Ppp2ca protein, rat MeSH Browser
- Protein Phosphatase 2 MeSH
- Sphingosine MeSH
- sphingosine 1-phosphate MeSH Browser
- Calcium MeSH
- Calcium Channels, L-Type MeSH
Modulation of Ca(2+) homoeostasis in cardiac myocytes plays a major role in beat-to-beat regulation of heart function. Previous studies suggest that sphingosine-1-phosphate (S1P), a biologically active sphingomyelin metabolite, regulates Ca(2+) handling in cardiac myocytes, but the underlying mechanism is unclear. In the present study, we tested the hypothesis that S1P-induced functional alteration of intracellular Ca(2+) handling includes the L-type calcium channel current (ICa,L) via a signalling pathway involving P21-activated kinase 1 (Pak1). Our results show that, in rat ventricular myocytes, S1P (100 nM) does not affect the basal activity of ICa,L but is able to partially reverse the effect of the β-adrenergic agonist Isoproterenol (ISO, 100 nM) on ICa,L. S1P (25 nM) also significantly prevents ISO (5 nM)-induced Ca(2+) waves and diastolic Ca(2+) release in these cells. Our further molecular characterisation demonstrates that Pak1 activity is increased in myocytes treated with S1P (25 nM) compared with those myocytes without treatment of S1P. By immunoprecipitation we demonstrate that Pak1 and protein phosphatase 2A (PP2A) are associated in ventricular tissue indicating their functional interaction. Thus the results indicate that S1P attenuates β-adrenergic stress-induced alteration of intracellular Ca(2+) release and L-type Ca(2+) channel current at least in part via Pak1-PP2A-mediated signalling.
Department of Pharmacology University of Oxford Oxford UK
Department of Physiology Anatomy and Genetics University of Oxford Oxford UK
Department of Physiology and Biophysics University of Illinois at Chicago Chicago USA
Egom Clinical and Translational Research Services Ltd Halifax NS B3H 4R7 Canada
Heart Efficiency Unit Cardiology Department The Adelaide and Meath Hospital Tallaght Dublin Ireland
See more in PubMed
J Biol Chem. 1997 Feb 21;272(8):4836-42 PubMed
Pharmacol Rev. 2000 Sep;52(3):375-414 PubMed
Genomics. 1998 Oct 15;53(2):164-9 PubMed
Gene. 1999 Feb 4;227(1):89-99 PubMed
J Cell Sci. 2004 Sep 1;117(Pt 19):4343-54 PubMed
Cardiovasc Res. 2009 May 1;82(2):193-200 PubMed
Cell. 2007 Jan 26;128(2):341-55 PubMed
J Biol Chem. 2001 Sep 7;276(36):33697-704 PubMed
Circ Res. 2007 May 11;100(9):1317-27 PubMed
Mol Pharmacol. 2000 Aug;58(2):449-54 PubMed
Biochem J. 2000 Jul 15;349(Pt 2):385-402 PubMed
Cancer Res. 2003 Sep 1;63(17):5446-53 PubMed
Pflugers Arch. 1999 Oct;438(5):642-8 PubMed
FEBS Lett. 2002 Oct 30;531(1):54-7 PubMed
J Clin Invest. 2000 Oct;106(8):951-61 PubMed
Annu Rev Biochem. 2003;72:743-81 PubMed
Am J Physiol Heart Circ Physiol. 2003 Aug;285(2):H735-44 PubMed
J Biol Chem. 1999 Jul 2;274(27):18997-9002 PubMed
Am J Physiol Cell Physiol. 2009 Jan;296(1):C47-58 PubMed
Biochim Biophys Acta. 2004 Jun 1;1682(1-3):48-55 PubMed
Biochem Biophys Res Commun. 1999 Jun 24;260(1):203-8 PubMed
Front Physiol. 2015 Mar 17;6:76 PubMed
Biochem Soc Trans. 2003 Dec;31(Pt 6):1216-9 PubMed
J Histochem Cytochem. 2002 May;50(5):661-70 PubMed
J Biol Chem. 2000 May 12;275(19):14281-6 PubMed
Br J Pharmacol. 2003 Dec;140(7):1163-8 PubMed
Eur J Biochem. 2000 Sep;267(18):5679-86 PubMed
Am J Physiol Heart Circ Physiol. 2011 Oct;301(4):H1487-95 PubMed
J Mol Cell Cardiol. 2010 Feb;48(2):406-14 PubMed
Circ Res. 2004 Feb 6;94(2):194-200 PubMed
Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H736-49 PubMed